Interpace Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.51	1.46	3.5	4.83	2.67
Cash & Short-Term Investments	2.51	1.46	3.5	4.83	2.67
Cash Growth	71.46%	-58.23%	-27.55%	80.69%	-3.61%
Accounts Receivable	5.65	8.54	5.08	5.03	4.67
Receivables	5.65	8.54	5.08	5.03	4.67
Inventory	1.11	1.21	1.23	1.22	0.83
Prepaid Expenses	0.63	0.54	0.59	0.39	0.58
Restricted Cash	-	-	-	-	0.25
Other Current Assets	-	0.02	0.02	0.68	3.16
Total Current Assets	9.9	11.77	10.42	12.15	12.17
Property, Plant & Equipment	2.64	2.97	2.65	2.92	1.6
Other Intangible Assets	-	-	-	0.86	2.13
Long-Term Deferred Tax Assets	21.25	-	-	-	-
Other Long-Term Assets	0.04	0.05	0.05	0.05	22.53
Total Assets	33.84	14.79	13.12	15.98	38.43
Accounts Payable	0.98	1.66	1.54	1.05	1.37
Accrued Expenses	2.7	3.33	3.01	7.9	9.04
Current Portion of Long-Term Debt	-	4.29	5.1	2.5	-
Current Portion of Leases	0.43	0.38	0.38	0.58	0.76
Current Income Taxes Payable	0.3	0.26	0.26	0.26	0.22
Other Current Liabilities	0.7	0.7	1.15	1.99	4.28
Total Current Liabilities	5.1	10.62	11.44	14.28	15.68
Long-Term Debt	-	-	4.24	11.17	9.44
Long-Term Leases	0.75	1.18	1.47	1.85	0.52
Other Long-Term Liabilities	5.62	5.21	4.97	5.22	8.67
Total Liabilities	11.48	17.01	22.12	32.52	34.31
Common Stock	0.41	0.41	0.41	0.41	0.4
Additional Paid-In Capital	234.83	234.81	188.15	187.52	186.11
Retained Earnings	-210.81	-235.38	-242.08	-249.02	-227.06
Treasury Stock	-2.07	-2.05	-2.01	-1.98	-1.87
Total Common Equity	22.36	-2.22	-55.54	-63.07	-42.42
Shareholders' Equity	22.36	-2.22	-9	-16.54	4.12
Total Liabilities & Equity	33.84	14.79	13.12	15.98	38.43
Total Debt	1.18	5.86	11.19	16.09	10.72
Net Cash (Debt)	1.32	-4.4	-7.69	-11.26	-8.05
Net Cash Per Share	0.05	-0.28	-1.76	-2.66	-1.95
Filing Date Shares Outstanding	27.7	4.42	4.38	4.31	4.23
Total Common Shares Outstanding	4.54	4.41	4.35	4.3	4.2
Working Capital	4.8	1.16	-1.02	-2.13	-3.52
Book Value Per Share	4.93	-0.50	-12.76	-14.68	-10.11
Tangible Book Value	22.36	-2.22	-55.54	-63.93	-44.55
Tangible Book Value Per Share	4.93	-0.50	-12.76	-14.88	-10.62
Machinery	3.96	3.47	2.81	2.55	2.22
Leasehold Improvements	0.48	0.48	0.27	0.18	0.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.